Classroom to business
Founded by current students, startup company Phyta aims to cultivate macroalgae, or seaweed, to be used as a sustainable alternative to consumer products like plastic, hygiene products and livestock feed.
Making transformative discoveries
UNC Gillings School of Global Public Health
The Gillings School of Global Public Health is improving public health, promoting individual well-being and eliminating health inequities across North Carolina and around the world. By bridging the gap between academic research and practical public health solutions, UNC Gillings School of Global Public Health researchers are anticipating threats and accelerating solutions that can save lives.
Press the play button to learn more about the school's mission and future.
As Carolina celebrates its 225th anniversary this year, we’ll spotlight the ways the University is preparing our students to thrive in a dynamic society and how it is opening the doors for great minds to make transformative discoveries. Throughout the year, we’ll profile academic units, hear from deans and learn about programs that set Carolina apart from other universities.
We are committed to outstanding teaching, research, scholarship and practice, and to bridging the gap between academic research and practical public health solutions.
Barbara K. Rimer, dean and professor
Impactful research
transforming medicine with artificial Intelligence
Biostatistics professor Michael Kosorok is leading the way in utilizing artificial intelligence to benefit public health.
Bringing healthy food to all consumers
UNC Gillings School of Global Public Health professor Alice Ammerman is working to provide locally-sourced, nutritious meals to communities in need.
Doctoral students recognized as outstanding social entrepreneurs with Forbes ’30 under 30’ award
Liz Chen and Cristina Leos were selected for Forbes magazine’s ’30 Under 30’ list of young entrepreneurs.
Fighting emerging diseases
The Baric Lab at the UNC Gillings School of Global Public Health is partnering with Gilead Sciences to make breakthrough drug developments to fight some of the world’s deadliest viruses.